Zusammenfassung
Vor nahezu 50 Jahren konnte erstmals gezeigt werden, daß der oxidative Stoffwechsel des Gehirns unter physiologischen Bedingungen ausschließlich auf der Nutzung von Glukose als Substrat der Energiegewinnung basiert [13]. Spätere Untersuchungen haben diesen Befund bestätigt und zudem dem zerebralen Glukose- und Energiestoffwechsel eine zentrale Stellung bei der Aufrechterhaltung normaler mentaler Funktionen zugewiesen [7,10,17, 19, 44], Aus Glukose werden im Gehirn der Neurotransmitter Acetylcholin [35] und die Aminosäurenneurotransmitter Glutamat, Aspartat, Glyzin und γ-Aminobuttersäure gebildet [2,40,56]. Glutamat und Aspartat haben exzi-tatorische, Glyzin und γ-Aminobuttersäure inhibitorische Wirkungen. Allein diese Beispiele verdeutlichen, daß eine Störung im zerebralen Glukosestoffwechsel zu erheblichen Beeinträchtigungen im Energie- und Neuro-transmitterhaushalt dieses Organs und damit zu mentalen Leistungseinbußen führen muß. Am Beispiel der Demenz vom Alzheimer-Typ sollen derartige pathobiochemische Vorgänge im Gehirn erläutert werden.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Bachelard HS (1971) Specific and kinetic properties of monosaccharide uptake into guinea pig cerebral cortex in vitro. J Neurochem 13:213–222
Barkulis SS, Geiger A, Kawikata Y, Aguilar V (1960) A study of the incorporation of 14C derived from glucose into free amino acids of the brain cortex. J Neurochem 5:339–348
Bowen DM, White P, Spillane JA et al. (1979) Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet 1:11–14
Bowen DM, Davison AN (1986) Biochemical sutdies of nerve cells and energy metabolism in Alzheimer’s disease. Br Med Bull 42:75–80
Blusztajn JK, Wurtman RJ (1983) Choline and cholinergic neurons. Science 221:614–620
Blusztajn JK, Maire JC, Tacconi MT, Wurtman RJ (1984) The possible role of neuronal choline metabolism in the pathophysiology of Alzheimer’s disease: A hypothesis. In: Wurtman RJ, Corkin SH, Growdon JH (eds) Alzheimer’s disease: Advances in basic research and therapies. Center Brain Sci Metabol, Cambridge MA, pp 183–198
Cohen PJ, Alexander SC, Smith TC, Reivich M, Wollman H (1967) Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man. J Appl Physiol 23:183–189
Cotman CW, Iversen LL (1987) Excitatory amino acids in the brain — focus on NMDA receptors. TINS 10:263–265
Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J (1987) Anatomical organization of excitatory amino acid receptors and their pathways. TINS 10:273–280
Erecinska M, Silver IA (1989) ATP and brain function. J Cereb Blood Flow Metab 9:2–19
Farooqui AA, Liss L, Horrocks LA (1988) Neurochemical aspects of Alzheimer’s disease: Involvement of membrane phopholipids. Metab Brain Dis 3:19–35
Friedland RP, Jagust WJ, Huesman RH et al. (1989) Regional cerebral glucose transport and utilization in Alzheimer’s disease. Neurology 39:1427–1434
Gibbs EL, Lennox WG, Nims LF, Gibbs FA (1942) Arterial and cerebral venous blood. Arterial-venous differences in man. J Biol Chem 144:325–332
Gibson GE, Jope R, Blass JP (1975) Reduced synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain. Biochem J 148:17–29
Goate AM, Haynes AR, Owen MJ et al. (1989) Predisposing locus for Alzheimer’s disease on chromosome 21. Lancet 1:352–355
Gottfries CG (1985) Alzheimer’s disease and senile dementia: Biochemical characteristics and aspects of treatment. Psychopharmacology 86:245–252
Gottstein U, Bernsmeier A, Sedlmeyer I (1963) Der Kohlenhydratstoffwechsel des menschlichen Gehirns. I. Untersuchung mit substratspezifischen enzymatischen Methoden bei normaler Hinrdurchblutung. Klin Wochenschr 41:943–948
Hertz MM, Paulson OB, Barry DI, Christiansen JS, Svendsen PA (1981) Insulin increases glucose transfer across the blood-brain barrier. J Clin Invest 67:597–604
Hoyer S (1970) Der Aminosäurenstoffwechsel des normalen menschlichen Gehirns. Klin Wochenschr 48:1239–1243
Hoyer S (1988) Glucose and related brain metabolism in dementia of Alzheimer type and its morphological significance. Age 11:158–166
Hoyer S, Nitsch R (1989) Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neurol Transm 75:227–232
Hoyer S, Oesterreich K, Wagner O (1988) Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J Neurol 235:143–148
Iwangoff P, Armbruster R, Enz A, Meier-Ruge W, Sandoz P (1980) Glycolytic enzymes from human autoptic brain cortex: Normally aged and demented cases. In: Roberts PJ (ed) Biochemistry of dementia. Wiley, Chichester, pp 258–262
Jahr CE, Stevens CF (1987) Glutamate activates multiple single channel conductances in hippocampal neurons. Nature 325:522–525
Jaspers K (1959) Allgemeine Psychopathologie, 7. Aufl. Springer, Berlin Göttingen Heidelberg, S 180–187
Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529–531
Khachaturian ZS (1984) Towards theories of brain ageing. In: Kay DWK, Burrows GD (eds) Handbook of studies on psychiatry and old age. Elsevier, Amsterdam, pp 7–30
Ksiezak-Reding H, Blass JP, Gibson GE (1982) Studies on the pyruvate dehydrogenase complex in brain with the arylanine acetyltransferase-coupled essay. J Neurochem 38:1627–1636
Leenders HJ, Berendes HD, Helmsing PJ, Derksen J, Koninkx JFJG (1974) Nuclear-mitochondrial interactions in the control of mitochondrial respitatory metabolism. Sub-cell Biochem 3:119–147
Lindquist S (1986) The heat-shock response. Ann Rev Biochem 55:1151–1191
Mann DMA, Yates PO, Marcyniuk B (1984) Alzheimer’s presenile dementia, senile dementia of Alzheimer type and Down’s syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10:185–207
Monaghan DT, Nolets VR, Toy DW, Cotman CW (1983) Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature 306:176–179
Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451:205–212
Olney JW, Ho OL, Rhee V (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res 14:61–76
Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH (1980) Coenzyme A acety-lating enzymes in Alzheimer’s disease: possible cholinergic „compartment” of pyruvate dehydrogenase. Neurosci Lett 18:105–110
Polinsky RJ, Noble H, Dichiro G, Nee LE, Feldman RG, Brown RT (1987) Domin-antly inherited Alzheimer’s disease: cerebral glucose metabolism. J Neurol Neurosurg Psychiatry 50:752–757
Roth M (1986) The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer’s disease. Br Med Bull 42:42–50
Rothman S (1984) Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 4:1884–1891
Rothman SM, Olney JW (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105–111
Sacks W (1965) Cerebral metabolism of double labeled glucose in human in vivo. J Appl Physiol 20:117–130
Salbaum JM, Weidemann A, Lemaire HG, Masters CL, Beyreuther K (1988) The promoter of Alzheimer’s disease amyloid A4 precursor gene. EMBO J 7:2807–2813
Schneider K (1959) Klinische Psychopathologie, 5. Aufl. Thieme, Stuttgart, S 63
Sheu KFR, Kim YP, Blass JP, Weksler ME (1985) An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer’s disease brain. Ann Neurol 17:444–449
Siesjö BK (1978) Brain energy metabolism. Wiley, Chichester, chapters 1, 6
Siesjö BK (1981) Cell damage in the brain: A speculative synthesis. J Cereb Blood Flow Metab 1:155–185
Siesjö BK, Wieloch T (1985) Cerebral metabolism in ischemia: neurochemical basis for therapy. Br J Anaesth 57:47–62
Sims NR, Bowen DM, Neary D, Davison AN (1983) Metabolic processes in Alzheimer’s disease: adenine nucleotide content and production of 14CO2 from (14-C) glucose in vitro in human neocortex. J Neurochem 41:1329–1334
Sims NR, Blass JP, Murphy C, Bowen DM, Neary D (1987) Phosphofructokinase activity in the brain in Alzheimer’s disease. Ann Neurol 21:509–510
Sims NR, Finegan JM, Blass JP, Bowen DM, Neary D (1987) Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 436:30–38
Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13:72–78
Strange PG (1988) The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system. Biochem J 249:309–318
Tucek S (1967) Subcellular distribution of acetyl-CoA synthetase, ATP citrate lyase, citrate synthetase, choline acetyltransferase, fumarate hydratase, and lactate dehydrogenase in mammalian brain tissue. J Neurochem 14:531–545
Tucek S (1978) Acetylcholine synthesis in neurons. Chapman & Hall, London
Wan B, LaNoue KF, Cheung JV, Scaduto RC Jr (1989) Regulation of citric acid cycle by calcium. J Biol Chem 264:13 430–13 439
Westerberg E, Deshpande JK, Wieloch T (1987) Regional differences in arachidonic acid release in rat hippocampal CA1 and CA3 regions during cerebral ischemia. J Cereb Blood Flow Metab 7:189–192
Wong KL, Tyce GM (1983) Glucose and amino acid metabolism in rat brain during sustained hypoglycemia. Neurochem Res 8:401–415
Zanotto L, Heinemann U (1983) Aspartate and glutamate induced reactions in extracellular free calcium and sodium concentration in area CA1 of „in vitro“hippocampal slices of rats. Neurosci Lett 35:79–84
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hoyer, S. (1992). Energiestoffwechsel und Neurotransmittersynthese im Gehirn bei Demenz vom Alzheimer-Typ. In: Lungershausen, E. (eds) Demenz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76932-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-76932-0_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76933-7
Online ISBN: 978-3-642-76932-0
eBook Packages: Springer Book Archive